Transient immune-mediated agranulocytosis following Mycoplasma pneumoniae infection

Luani Barge1, Gail Pahn2, Nicholas Weber1,3

  • 1Haematology Department, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

BMJ Case Reports
|April 20, 2018
PubMed

Insights

Mycoplasma pneumoniae infection can rarely cause severe neutropenia (low white blood cell count). This case highlights a potential link and successful treatment with azithromycin and G-CSF.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Immunology

Background:

  • Mycoplasma pneumoniae is a common respiratory pathogen.
  • It can cause various hematological issues, such as hemolytic anemia and thrombocytopenia.
  • Severe neutropenia is an uncommon but serious manifestation.

Observation:

  • An 85-year-old male patient presented with agranulocytosis during an exacerbation of chronic obstructive pulmonary disease.
  • Serological testing confirmed Mycoplasma pneumoniae infection.
  • No other causes for neutropenia were identified, and the patient tested positive for neutrophil autoantibodies.

Findings:

  • The patient's neutropenia was directly linked to Mycoplasma pneumoniae infection.
  • Treatment with azithromycin and granulocyte colony-stimulating factor (G-CSF) led to a complete and sustained recovery of neutrophil counts.

Implications:

  • This case underscores the importance of considering Mycoplasma pneumoniae as a potential cause of severe neutropenia, even in elderly patients.
  • Early diagnosis and appropriate treatment, including antibiotics and G-CSF, can lead to favorable outcomes.
  • Further research may elucidate the immunological mechanisms underlying this rare complication.